អ៊ិនមីដអិល: “It sells for incredibly cheap. … Frankly, I don’t get it, and that makes me want to look more into it, not just say buy.”
អេសស៊ីថលអិលធីឌី: “They’re losing too much money, to be honest. I’m baffled. … That’s what I don’t like about it.”
Source: https://www.cnbc.com/2023/01/24/cramers-lightning-round-amicus-therapeutics-is-an-ideal-spec.html